Nutriband Inc (NTRB) Stock Price, Quote & News

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Industry: Biotechnology

Sector: Healthcare

Phone: 407 377 6695

Website: www.nutriband.com

Address:

121 South Orange Avenue, Suite 1500, Orlando, United States

birdmanCap Jun. 23 at 6:32 PM

$NTRB

0 · Reply

Covode13 Jun. 23 at 3:21 PM

$NTRB

0 · Reply

birdmanCap Jun. 22 at 2:11 PM

$NTRB good news today 🙌🏻

1 · Reply

Covode13 Jun. 22 at 2:03 PM

$NTRB any of the other board members leaving to join the government hahah

0 · Reply

NNTrader Jun. 22 at 1:07 PM

$NTRB bullish

0 · Reply

Covode13 Jun. 22 at 1:31 AM

$NTRB

0 · Reply

JhonHack Jun. 18 at 11:48 PM

$NTRB WHAT. A. TURD. Give us worthless shares for an approval that isn’t coming, big boys sell and run for president of their home country and then live large while we slowly bleed out. I’ve been here for 7 years. This should have never, ever dipped below $3 again.

1 · Reply

Covode13 Jun. 15 at 8:57 PM

$NTRB this just got marked as very high risk. I think this will be a bust of a company

3 · Reply

birdmanCap Jun. 15 at 6:18 PM

$NTRB this always has a pop upwards when volume is drying up down here Watching closely

0 · Reply

Covode13 Jun. 15 at 2:18 PM

$NTRB what a piece of 💩. They might never get this FDA approved.

0 · Reply

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

NTRBW

Apr 22, 2026, 7:00 AM EDT - 2 months ago

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

NTRBW

Mar 30, 2026, 4:05 PM EDT - 3 months ago

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

NTRBW

2026-03-18T11:16:16.000Z - 3 months ago

Nutriband’s Kinesiology Tapes approved for distribution and sale in Costa Rica

Feb 17, 2026, 7:28 AM EST - 4 months ago

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

NTRBW

2026-02-17T12:17:11.000Z - 4 months ago

Nutriband signs exclusive distribution agreement with Innomedica

2026-01-30T12:20:44.000Z - 5 months ago

Nutriband provides summary of annual shareholder meeting

Jan 30, 2026, 7:00 AM EST - 5 months ago

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

NTRBW

2025-12-31T12:10:36.000Z - 6 months ago

Nutriband says ‘committed’ to shareholder value as ‘number one focus’

Dec 31, 2025, 7:00 AM EST - 6 months ago

Nutriband CEO Publishes Letter to Shareholders

NTRBW

2025-12-29T14:05:16.000Z - 6 months ago

Nutriband to sell majority stake of Pocono Pharmaceutical for $5M

Dec 29, 2025, 9:00 AM EST - 6 months ago

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

NTRBW

2025-12-18T13:05:49.000Z - 6 months ago

Nutriband signs LOI with Qvanta Group of companies

2025-12-18T12:10:38.000Z - 6 months ago

Nutriband provides response to Trump’s Executive Order related to fentanyl

Dec 18, 2025, 7:00 AM EST - 6 months ago

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

NTRBW

Nov 24, 2025, 7:00 AM EST - 7 months ago

Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference

NTRBW

Oct 28, 2025, 11:05 AM EDT - 8 months ago

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

NTRBW

2025-10-28T11:15:36.000Z - 8 months ago

Nutriband announces meeting completed with U.S. FDA for AVERSA FENTANYL

Oct 28, 2025, 7:00 AM EDT - 8 months ago

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

NTRBW

2025-10-27T11:11:14.000Z - 8 months ago

Nutriband co-founder Gareth Sheridan returns as CEO

2025-10-10T11:05:38.000Z - 9 months ago

Nutriband signs agreement with Brand Institute to develop brand for patch

Oct 10, 2025, 7:00 AM EDT - 9 months ago

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

NTRBW

2025-10-08T12:41:02.000Z - 9 months ago

Nutriband files provisional patent application for AVERSA technology

Oct 8, 2025, 8:30 AM EDT - 9 months ago

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

NTRBW

Oct 8, 2025, 6:30 AM EDT - 9 months ago

Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference

NTRBW

Sep 24, 2025, 4:05 PM EDT - 9 months ago

Nutriband Inc. to Present at the MicroCap Rodeo Conference

NTRBW

2025-09-10T13:20:17.000Z - 10 months ago

Nutriband reports Q2 EPS ($2.12) vs. (15c) last year

Sep 10, 2025, 9:15 AM EDT - 10 months ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

NTRBW

Sep 3, 2025, 4:01 PM EDT - 10 months ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

NTRBW

Aug 18, 2025, 9:00 AM EDT - 11 months ago

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

2025-08-11T09:10:24.000Z - 11 months ago

Nutriband CEO Gareth Sheridan steps aside for Irish election

Aug 11, 2025, 5:00 AM EDT - 11 months ago

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

NTRBW

2025-08-08T12:11:35.000Z - 11 months ago

Nutriband announces FDA granted Type C Meeting for AVERSA FENTANYL

Aug 8, 2025, 8:00 AM EDT - 11 months ago

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

2025-07-18T13:20:11.000Z - 1 year ago

Nutriband confirms record, pay date for 25% preferred stock dividend

Jul 18, 2025, 9:15 AM EDT - 1 year ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

NTRBW

2025-07-02T12:21:15.000Z - 1 year ago

Nutriband board approves 25% Preferred Stock dividend

Jul 2, 2025, 8:05 AM EDT - 1 year ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

NTRBW

2025-07-01T11:15:18.000Z - 1 year ago

Nutriband added to Russell Microcap, Russell Microcap Growth, Russell 3000E

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

NTRBW

2025-06-18T11:05:42.000Z - 1 year ago

Nutriband, Kindeva complete commercial manufacturing process scale-up for Aversa

Jun 9, 2025, 7:30 AM EDT - 1 year ago

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

NTRBW

Apr 11, 2025, 7:00 AM EDT - 1 year ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

NTRBW

Apr 4, 2025, 5:41 PM EDT - 1 year ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

NTRBW

Apr 4, 2025, 7:00 AM EDT - 1 year ago

Nutriband Signs Partnership Agreement with Charlotte FC

NTRBW

Feb 21, 2025, 7:00 AM EST - 1 year ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

NTRBW

Feb 13, 2025, 7:00 AM EST - 1 year ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Feb 7, 2025, 8:45 AM EST - 1 year ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

NTRBW

Dec 31, 2024, 7:00 AM EST - 1 year ago

Nutriband Issues Letter to Shareholders

NTRBW

Dec 27, 2024, 9:25 AM EST - 1 year ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

NTRBW

Dec 4, 2024, 9:00 AM EST - 1 year ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Nov 27, 2024, 7:00 AM EST - 1 year ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

NTRBW

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

NTRBW

Oct 17, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

NTRBW

Oct 2, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

NTRBW

Sep 24, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

NTRBW

Sep 20, 2024, 6:50 AM EDT - 1 year ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

NTRBW

Sep 16, 2024, 4:00 PM EDT - 1 year ago

Nutriband Inc. Authorizes $1M Share Buyback Program

NTRBW

Sep 4, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Jul 19, 2024, 7:00 AM EDT - 2 years ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

NTRBW

Jul 15, 2024, 7:00 AM EDT - 2 years ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

NTRBW

Jun 20, 2024, 7:00 AM EDT - 2 years ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

NTRBW

Jun 3, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

NTRBW

May 16, 2024, 7:00 AM EDT - 2 years ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

NTRBW

May 10, 2024, 9:00 AM EDT - 2 years ago

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

CANF

Apr 23, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

NTRBW

Apr 19, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Announces $8.4M Private Placement

NTRBW

Mar 25, 2024, 7:00 AM EDT - 2 years ago

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

birdmanCap Jun. 23 at 6:32 PM

$NTRB

0 · Reply

Covode13 Jun. 23 at 3:21 PM

$NTRB

0 · Reply

birdmanCap Jun. 22 at 2:11 PM

$NTRB good news today 🙌🏻

1 · Reply

Covode13 Jun. 22 at 2:03 PM

$NTRB any of the other board members leaving to join the government hahah

0 · Reply

NNTrader Jun. 22 at 1:07 PM

$NTRB bullish

0 · Reply

Covode13 Jun. 22 at 1:31 AM

$NTRB

0 · Reply

JhonHack Jun. 18 at 11:48 PM

1 · Reply

Covode13 Jun. 15 at 8:57 PM

$NTRB this just got marked as very high risk. I think this will be a bust of a company

3 · Reply

birdmanCap Jun. 15 at 6:18 PM

$NTRB this always has a pop upwards when volume is drying up down here Watching closely

0 · Reply

Covode13 Jun. 15 at 2:18 PM

$NTRB what a piece of 💩. They might never get this FDA approved.

0 · Reply

birdmanCap Jun. 15 at 11:50 AM

$NTRB due a pop again. Trades up at least once a year from these levels I think maybe 4 times now Iv picked up shares at these levels and was able to sell at double my price

0 · Reply

BullInvest Jun. 14 at 9:07 PM

$NTRB does anyone even know any type of update? All I see is Sheridan on IG popping drinks with friends in different parts of the world like he is a fraternity boy. Wasn’t he supposed to be running this??

0 · Reply

NNTrader Jun. 12 at 6:38 PM

$NTRB added some

0 · Reply

d_risk Jun. 12 at 3:35 PM

$NTRB - NutriBand Inc. - 10Q - Updated Risk Factors NTRB’s latest 10‑Q sharpens risks around U.S. policy and global instability hitting FDA timelines, costs, pricing and capital access, underscores its lack of any approved products or clear path to profitability, flags heavier dependence on financing with potential deep dilution and stock pressure, and adds explicit warnings that rapid drug‑delivery tech shifts could render its platform obsolete and even force shutdown. 🟢 Added 🟠 Removed https://d-risk.ai/NTRB/10-Q/2026-06-11

0 · Reply

birdmanCap Jun. 8 at 10:44 PM

$NTRB

0 · Reply

Covode13 Jun. 8 at 12:18 PM

$NTRB

0 · Reply

Covode13 Jun. 2 at 11:54 AM

$NTRB

0 · Reply

Covode13 May. 27 at 10:55 PM

$NTRB 💩

0 · Reply

birdmanCap May. 26 at 1:03 PM

$NTRB

2 · Reply

Covode13 May. 18 at 10:51 PM

$NTRB got all these extra shares for nothing. I’ll have them till the day I die haha 40 plus years away

1 · Reply

nutriband_com May. 15 at 9:14 PM

$NTRB Nutriband and Active Intelligence will showcase expanding AI wellness and recovery products at the upcoming ECRM Conference. Meetings scheduled with buyers from Walmart, Walgreens, Amazon, Cardinal Health and other major retailers. New launches include AI Energy Patches, AI Sleep and AI Performance Tape. https://www.nutriband.com/post/nutriband-inc-to-showcase-expanding-ai-wellness-product-portfolio-and-new-june-product-launches-at-e #NTRB #healthcare #wellness #retail

0 · Reply

NetworkNewsWire May. 15 at 5:27 PM

BioMedNewsBreaks — $NTRB Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference https://ibn.fm/MdpEg

0 · Reply

Market Cap	37.08M
Revenue (ttm)	2.04M
Net Income (ttm)	-8.23M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-403.43%
Debt to Equity Ratio	0.01

Volume	13,100
Avg Vol	10,560
Day's Range	N/A - N/A
Shares Out	12.16M
Stochastic %K	38%
Beta	1.90
Analysts	Strong Sell
Price Target	$15.00